NCT06021795Recruiting
Sounds for Sleep Study in Patients Suffering From Moderate to Severe Insomnia
Third Wave TherapeuticsClinicalTrials.govdeviceDevice trial
Study focus
- Disease/Condition
- Insomnia
- Drug/Device/Intervention
- Sound Treatment
- Study type
- Interventional
- Intervention type
- device
Sponsor & location
- Primary sponsor
- Third Wave Therapeutics
- Location
- San Francisco, United States of America
Timeline & enrollment
- Phase
- N/A
- Start date
- Aug 01, 2023
- End date
- Mar 31, 2024
- Enrollment
- 25 participants
Primary outcome
Change in Insomnia Severity Index (ISI)
Summary
Assess the effect of a customized audio track delivered via standard commercially-available
 bone conduction headsets on the quality of sleep
ICD-10 classifications
Nonorganic insomniaDisorders of initiating and maintaining sleep [insomnias]Sleep disordersSleep disorder, unspecifiedOther sleep disorders
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06021795
- Type
- Device Trial
About this record
Access comprehensive clinical trial information for NCT06021795 through Pure Global AI's free database. This phase not specified trial is sponsored by Third Wave Therapeutics and is currently Recruiting. The study focuses on Insomnia. Target enrollment is 25 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.